Complete DYAI Stock Valuation Analysis
Comprehensive intrinsic value analysis using 2 different methodologies
DYAI DCF Analysis
DYAI (Dyadic International, Inc.) discounted cash flow analysis with multiple scenarios, growth assumptions, and terminal value calculations
Financial Projections
Metrics | 2022 (Historical) | 2023 (Historical) | 2024 (Historical) | 2025 (Projected) | 2026 (Projected) | 2027 (Projected) | 2028 (Projected) | 2029 (Projected) |
---|---|---|---|---|---|---|---|---|
Revenue | $2.9M | $2.9M | $3.5M | $4.1M | $4.7M | $5.4M | $6.1M | $6.8M |
Revenue Growth % | - | -1.1% | 20.6% | 17.3% | 15.6% | 14.0% | 12.6% | 11.3% |
EBIT | $-10.1M | $-8.2M | $-5.9M | $205.0K | $236.9K | $270.1K | $304.2K | $338.7K |
EBIT Margin % | -345.2% | -283.9% | -168.8% | 5.0% | 5.0% | 5.0% | 5.0% | 5.0% |
Tax Rate % | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
NOPAT | $-7.6M | $-6.2M | $-4.4M | $153.7K | $177.7K | $202.6K | $228.1K | $254.0K |
NOPAT Margin % | -258.9% | -212.9% | -126.6% | 3.8% | 3.8% | 3.8% | 3.8% | 3.8% |
Capex | $0 | $0 | $0 | $41.0K | $47.4K | $54.0K | $60.8K | $67.7K |
Capex / Revenue % | 0.0% | 0.0% | 0.0% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% |
Depreciation | $33.8K | $0 | $-71.1K | $-12.0K | $-13.9K | $-15.8K | $-17.8K | $-19.9K |
D&A / Revenue % | 1.2% | 0.0% | -2.0% | -0.3% | -0.3% | -0.3% | -0.3% | -0.3% |
Change in NWC | $-7.5M | $-5.2M | $1.6M | $0 | $0 | $0 | $0 | $0 |
NWC Change / Revenue % | -255.2% | -177.9% | 44.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Unlevered FCF | $-73.9K | $-1.0M | $-6.1M | $100.7K | $116.4K | $132.7K | $149.4K | $166.4K |
UFCF % Chg. | - | -1272.5% | -497.5% | 101.7% | 15.6% | 14.0% | 12.6% | 11.3% |
FCF / Revenue % | -2.5% | -35.0% | -173.4% | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% |
Discount Factor | - | - | - | 0.927 | 0.860 | 0.797 | 0.739 | 0.686 |
Present Value of FCF | - | - | - | $93.4K | $100.1K | $105.8K | $110.5K | $114.1K |
Sum of PV of UFCF | - | - | - | $93.4K | $193.5K | $299.3K | $409.8K | $523.9K |
WACC Calculation
Weighted Average Cost of Capital used for discounting cash flows.
WACC Calculation | Value |
---|---|
Cost of Debt | 6.9% |
Tax Rate | 25.0% |
After Tax Cost of Debt | 5.2% |
Risk Free Rate | 4.40% |
Market Risk Premium | 4.3% |
Beta | 0.90 |
Cost of Equity | 8.3% |
Total Debt | $5.1M |
Market Cap | $29.7M |
Total Capital | $34.7M |
Debt Weighting | 14.6% |
Equity Weighting | 85.4% |
WACC | 7.8% |
Terminal Value
Choose between perpetuity growth or exit multiple methods.
Terminal Value Calculation | Value |
---|---|
Terminal Growth Rate | 2.5% |
Final Year FCF | $166.4K |
Terminal Value | $3.2M |
PV of Terminal Value | $2.2M |
Cumulative PV of UFCF | $523.9K |
Net Debt | $-1.4M |
Equity Value | $4.2M |
Shares Outstanding | 29.3M |
Implied Share Price | $0 |
Current Share Price | $1 |
Implied Upside/(Downside) | -85.6% |
Valuation Summary
$0.14
Implied Price
$0.99
Current Price
-85.6%
Upside/Downside
7.8%
WACC
DYAI Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 7 peer companies in Healthcare
P/E Ratio
$0.00
-100.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.99
+0.0%
Peer Median: 8.3x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for DYAI's business model and current situation.
Multiple Comparison
Multiple | DYAI Current | Peer Median | Peer Average | Premium/Discount | Assessment |
---|---|---|---|---|---|
P/E Ratio | -5.1x | 0.0x | 0.0x | -Infinity% | Undervalued |
EV/EBITDA | Infinityx | 0.0x | 0.0x | Infinity% | Overvalued |
P/S Ratio | 8.3x | 8.3x | 7.1x | 0.0% | Fair Value |
Peer Companies
Click any company to view their valuation
Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
---|---|---|---|---|
$0.03B | 0.0x | 0.0x | 0.0x | |
$0.03B | 0.0x | 0.0x | 0.0x | |
$0.03B | 0.0x | 0.0x | 1.0x | |
$0.03B | 0.0x | 0.0x | 8.3x | |
$0.03B | 0.0x | 0.0x | 31.2x | |
$0.00B | 0.0x | 0.0x | 329.5x | |
$0.03B | 0.0x | 0.0x | 19.1x |